patient
receiv
corticosteroid
acut
continu
oral
steroid
therapi
home
day
cours
less
week
taper
requir
cours
remain
need
taper
patient
concurr
take
inhal
formul
dose
paramet
controversi
choos
moder
regimen
mg
prednison
per
day
patient
alreadi
control
medic
mild
persist
asthma
start
lowdos
inhal
corticosteroid
oral
leukotrien
modifi
zafirlukast
montelukast
longact
bagonist
salmeterol
ad
regimen
patient
moder
persist
asthma
inadequ
control
inhal
corticosteroid
patient
advis
use
shortact
bagonist
regularli
schedul
basi
day
need
patient
educ
provid
discharg
well
appoint
followup
visit
within
sever
week
import
treat
pregnant
asthmat
aggress
prevent
matern
hypoxia
subsequ
fetal
morbid
mortal
patient
undertr
fear
teratogen
risk
respiratori
failur
sever
acut
asthma
greater
therapi
standard
medic
standard
therapi
dosag
copd
chronic
obstruct
pulmonari
diseas
exercis
extrem
caution
patient
known
coronari
arteri
diseas
albuterol
nebul
solut
mgml
mg
everi
minut
three
dose
copd
diseas
character
chronic
airflow
limit
fulli
revers
progress
associ
abnorm
inflammatori
respons
noxiou
particl
gase
combin
small
airway
diseas
parenchym
destruct
includ
emphysema
chronic
bronchiti
coexist
asthma
characterist
symptom
copd
cough
sputum
product
dyspnea
exert
exacerb
character
increas
dyspnea
often
accompani
wheez
chest
tight
increas
cough
sputum
chang
color
thick
sputum
fever
smoke
exposur
occup
dust
chemic
air
pollut
common
caus
copd
n
patient
present
wheez
differenti
diagnosi
includ
asthma
chf
pneumonia
cardiogen
pulmonari
edema
bronchiti
n
present
dyspnea
differenti
diagnosi
includ
myocardi
ischemia
pericardi
effus
pneumothorax
pulmonari
embol
pneumonia
asthma
acut
respiratori
distress
syndrom
ard
bronchiectasi
pulmonari
fibrosi
pleural
effus
tuberculosi
metabol
disturb
acidosi
shock
puls
oximetri
use
everi
patient
copd
oxygen
satur
less
indic
sever
hypoxia
arteri
blood
ga
measur
often
identifi
patient
increas
continu
hypoxia
hypercarbia
respiratori
acidosi
especi
compar
patient
baselin
valu
check
theophyllin
level
indic
chest
radiograph
appropri
copd
exacerb
help
manag
complic
concomit
diseas
patient
cor
pulmonal
continu
cardiac
monitor
may
identifi
associ
arrhythmia
use
btype
natriuret
peptid
bnp
substitut
clinic
judgment
tri
differenti
copd
chf
numer
cutoff
valu
differenti
two
diseas
remain
elus
contrast
asthma
acut
pulmonari
function
test
less
help
emerg
set
difficulti
sick
patient
copd
perform
test
properli
differenti
mild
moder
sever
copd
reli
fev
ratio
fev
forc
vital
capac
fvc
make
calcul
without
formal
pulmonari
function
test
pft
gener
possibl
ed
key
object
treat
copd
exacerb
achiev
key
object
reliev
hypoxemia
allevi
revers
bronchospasm
treat
underli
etiolog
exacerb
cornerston
initi
manag
treat
hypoxia
supplement
oxygen
goal
oxygen
satur
greater
despit
adequ
oxygen
satur
co
retent
due
obstruct
natur
diseas
occur
insidi
littl
chang
symptom
thu
oxygen
administr
care
monitor
frequent
clinic
assess
continu
puls
oximetri
arteri
blood
gase
need
excess
supplement
oxygen
small
subset
patient
caus
respiratori
arrest
secondari
loss
hypoxemiainduc
ventilatori
drive
relief
airflow
obstruct
bronchoconstrict
usual
accomplish
administr
either
intermitt
dose
aerosol
b
agonist
anticholinerg
ipratropium
system
corticosteroid
indic
sever
exacerb
copd
use
methylxanthin
theophyllin
aminophyllin
remain
controversi
use
inadequ
respons
shortact
bronchodil
routin
antibiot
coverag
controversi
global
initi
chronic
obstruct
lung
diseas
gold
guidelin
recommend
antibiot
therapi
patient
three
cardin
symptom
increas
dyspnea
increas
sputum
volum
increas
sputum
purul
patient
requir
invas
noninvas
mechan
ventil
antibiot
choic
reflect
local
antibiot
sensit
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
guidelin
treatment
pneumonia
present
consid
ask
patient
feel
reexamin
monitor
oxygen
satur
patient
abl
perform
object
measur
pulmonari
function
compar
fev
pefr
best
three
attempt
obtain
present
obtain
treatment
noninvas
modal
continu
posit
airway
pressur
cpap
bilevel
posit
airway
pressur
bipap
often
obviat
need
intub
improv
ga
exchang
decreas
hypoxia
reduc
work
breath
noninvas
intermitt
ventil
niv
studi
sever
random
control
trial
consist
provid
posit
result
success
rate
patient
unabl
toler
niv
respond
niv
chang
mental
statu
increas
respiratori
distress
cyanosi
acut
deterior
respiratori
arrest
shock
sever
acidosi
ph
hypercapnia
paco
mm
hg
intub
mechan
ventil
immedi
relaps
rate
remain
high
patient
copd
less
respiratori
reserv
function
quickli
revers
patient
often
take
longer
ed
visit
recov
requir
hospit
failur
improv
ed
fail
outpati
manag
concern
pulmonari
infect
reason
hospit
patient
return
near
baselin
improv
ed
treatment
good
social
support
system
place
may
discharg
home
close
followup
patient
receiv
corticosteroid
acut
continu
oral
steroid
therapi
home
day
dose
paramet
controversi
choos
moder
regimen
mg
prednison
per
day
taper
requir
patient
continu
use
shortact
rescu
medic
ad
inhal
anticholinerg
plu
longeract
sympathomimet
bronchodil
may
improv
lung
function
help
improv
effect
pulmonari
rehabilit
use
chronic
inhal
corticosteroid
benefici
patient
fev
l
antibiot
prescrib
patient
deem
well
enough
discharg
experienc
increas
sputum
product
thick
chang
sputum
color
patient
paco
lower
mm
hg
baselin
evalu
home
oxygen
therapi
patient
educ
provid
discharg
well
appoint
followup
visit
within
sever
day
ipratropium
bromid
contain
deriv
soy
lecithin
relat
food
product
patient
soybean
peanut
allergi
may
develop
anaphylaxi
expos
medic
either
meter
dose
inhal
mdi
nebul
form
reliev
signific
hypoxemia
oxygen
revers
airflow
obstruct
bagonist
ipratropium
consid
antibiot
chang
sputum
product
patient
copd
less
respiratori
reserv
requir
admiss
frequent
patient
asthma
cpap
bipap
may
obviat
need
endotrach
intub
adequ
discharg
plan
includ
educ
medic
care
followup
pneumonia
seventh
lead
caus
death
overal
lead
caus
death
infecti
diseas
unit
state
approxim
million
identifi
case
communityacquir
pneumonia
cap
year
result
million
hospit
admiss
ed
serv
portal
entri
admiss
properli
identifi
treat
outpati
mortal
cap
decreas
overal
mortal
decreas
sinc
role
emerg
physician
diagnos
pneumonia
accur
initi
time
antibiot
therapi
make
appropri
disposit
pneumonia
infect
alveolar
space
lung
commonli
develop
via
inhal
infecti
particl
aspir
oropharyng
gastric
content
less
commonli
hematogen
spread
infect
direct
invas
contigu
structur
direct
inocul
reactiv
prior
diseas
differ
present
typic
pneumonia
atyp
pneumonia
n
typic
pneumonia
present
abrupt
onset
high
fever
cough
product
purul
sputum
short
breath
pleurit
chest
pain
infant
may
present
fever
associ
irrit
tachypnea
intercost
retract
nasal
flare
grunt
cough
may
absent
infant
elderli
debilit
patient
may
present
nonspecif
complaint
find
confus
deterior
baselin
function
rather
classic
symptom
common
organ
streptococcu
pneumonia
n
atyp
pneumonia
insidi
onset
includ
promin
cough
often
absenc
sputum
product
patient
may
mild
fever
like
extrapulmonari
manifest
sore
throat
dermat
headach
cardiac
complic
ie
pericard
myocard
hepat
renal
diseas
consist
clinic
radiograph
criteria
avail
distinguish
typic
atyp
pneumonia
common
organ
mycoplasma
pneumonia
caus
organ
unknown
patient
cap
patient
caus
organ
known
pneumonia
common
agent
see
tabl
hospit
exposur
virul
organ
chang
pattern
infect
gramneg
bacilli
particularli
klebsiella
pseudomona
aeruginosa
escherichia
coli
respons
case
staphylococcu
aureu
account
anoth
hospitalacquir
pneumonia
tend
associ
sever
case
remaind
case
usual
due
anaerob
oral
flora
pneumonia
legionella
moraxella
catarrhali
account
case
nosocomi
acquir
pneumonia
rise
rapidli
case
may
account
pneumonia
patient
return
ed
patient
develop
hospitalacquir
pneumonia
attribut
mortal
patient
pneumonia
usual
present
cough
dyspnea
sputum
product
fever
pleurit
chest
pain
physic
examin
may
show
evid
alveolar
fluid
inspiratori
copd
chronic
obstruct
pulmonari
diseas
cva
cerebrovascular
accid
et
endotrach
nt
nasotraadapt
wwwclevelandclinicmededcomdiseasemanagementinfectiousdiseasecommunitypneumoniahtm
other
adapt
wwwclevelandclinicmededcomdiseasemanagementinfectiousdiseasecommunitypneumoniahtm
percentag
virus
highli
variabl
high
one
studi
may
higher
infant
young
children
adult
rale
consolid
bronchial
breath
sound
pleural
effus
dull
decreas
breath
sound
bronchial
congest
rhonchi
wheez
find
consist
pneumonia
includ
fever
tachypnea
tachycardia
decreas
oxygen
satur
alter
mental
statu
associ
sever
ill
although
provid
treat
healthi
lowrisk
patient
suspect
pneumonia
empir
other
feel
chest
xray
mandatori
everi
patient
histori
symptom
suggest
pneumonia
difficult
identifi
set
specif
criteria
order
chest
xray
patient
present
cough
need
chest
radiographi
clinic
judgment
must
use
presenc
clinic
indic
american
thorac
societi
at
infecti
diseas
societi
america
idsa
includ
radiograph
find
part
definit
pneumonia
idsa
pneumonia
guidelin
state
execut
summari
addit
constel
suggest
clinic
featur
demonstr
infiltr
chest
radiograph
imag
techniqu
without
support
microbiolog
data
requir
diagnosi
pneumonia
arteri
blood
ga
may
augment
inform
obtain
puls
oximetri
assess
need
respiratori
support
addit
follow
laboratori
test
may
use
aid
risk
stratif
patient
complet
blood
count
serum
electrolyt
use
sputum
gram
stain
blood
cultur
controversi
xray
find
may
suggest
underli
microbi
etiolog
overlap
variat
radiograph
sign
differ
organ
may
lead
misclassif
xray
diagnost
specif
pathogen
chest
xray
help
defin
extent
locat
infiltr
eg
perihilar
multilobar
involv
addit
dehydr
radiograph
manifest
chronic
diseas
may
obscur
infiltr
pneumonia
see
tabl
diagnosi
pneumonia
strongli
suspect
histori
physic
xray
result
next
decis
whether
patient
appropri
discharg
requir
hospit
admiss
severityofil
score
criteria
confus
uremia
respiratori
rate
low
blood
pressur
age
year
greater
prognost
model
pneumonia
specif
sever
ill
psi
use
disposit
aid
psi
use
combin
paramet
evalu
patient
assign
diseas
sever
mortal
risk
guid
disposit
see
tabl
prognost
accuraci
effect
safeti
decis
aid
psi
becom
refer
standard
risk
stratif
although
clear
guidelin
intens
care
unit
icu
admiss
sever
rule
publish
patient
requir
ventilatori
assist
pressor
alter
mental
statu
multilobar
bilater
infiltr
pleural
effus
age
comorbid
condit
respiratori
rate
heart
rate
sat
white
blood
cell
count
blood
urea
nitrogen
bun
ph
sodium
among
patient
consid
icu
set
support
care
includ
oxygen
ventilatori
support
given
requir
rehydr
antipyret
pain
control
also
start
indic
antibiot
therapi
begin
base
like
pathogen
soon
diagnosi
pneumonia
made
strongli
suspect
studi
shown
decreas
mortal
length
stay
group
patient
admit
cap
antibiot
administ
within
rang
hour
arriv
patient
admit
pneumonia
ed
first
dose
antibiot
begun
prior
transfer
floor
icu
choic
antibiot
begin
base
site
treatment
suspect
pathogen
suggest
tabl
use
consider
clinic
pictur
recent
literatur
local
prefer
resist
pattern
increas
evid
strengthen
recommend
combin
empir
therapi
sever
cap
presenc
comorbid
chronic
heart
lung
liver
renal
diseas
diabet
mellitu
alcohol
malign
asplenia
immunosuppress
condit
influenc
empir
choic
antimicrobi
valu
gram
stain
expector
sputum
controversi
uncertain
accur
expector
sputum
reflect
lower
respiratori
tract
secret
patholog
gram
stain
frequent
neg
specif
organ
result
rare
chang
therapi
gram
stain
may
use
highrisk
hospit
patient
consid
group
use
sputum
stain
acidfast
tb
techniqu
direct
fluoresc
antibodi
stain
continu
develop
role
probabl
help
ed
manag
patient
util
blood
cultur
determin
caus
agent
unselect
patient
cap
rare
alter
therapi
patient
present
ed
pneumonia
discriminatori
use
may
potenti
reduc
resourc
util
howev
patient
sever
symptom
signific
risk
factor
blood
cultur
may
demonstr
uncommon
caus
organ
unexpect
antibiot
resist
current
guidelin
suggest
blood
cultur
obtain
ed
prior
initi
antibiot
hospit
patient
requir
icu
admiss
cavitari
lesion
leukopenia
activ
alcohol
abus
sever
liver
diseas
asplenia
pleural
effus
begin
empir
treatment
earli
base
suspect
pathogen
calcul
psi
score
reliabl
predictor
mortal
tool
assist
disposit
decis
support
oxygen
ventil
circul
indic
patient
condit
recent
hospit
nurs
home
patient
infect
differ
organ
requir
addit
antibiot
coverag
consid
present
typic
versu
atyp
make
therapi
decis
